文献速递神经肿瘤

垂体腺瘤手术与焦虑障碍的相关性:系统综述与Meta分析

Correlation Between Pituitary Adenoma Surgery and Anxiety Disorder: Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2024-04-30

该系统综述与Meta分析检索至2022年10月,纳入32项研究共2681例垂体腺瘤患者,其中17项研究1510例进入Meta分析。术前术后HADS评分分别为8.27与6.49,SAS评分分别为50.43与55.91,均无显著差异。作者认为焦虑水平在手术前后保持稳定,但证据存在局限,需进一步研究。

要点

  • 垂体腺瘤手术前后HADS焦虑评分无显著差异(术前8.27 vs 术后6.49)。
  • 垂体腺瘤手术前后SAS焦虑评分无显著差异(术前50.43 vs 术后55.91)。
  • 垂体功能不全是原文报告的最常见并发症。

核心结论

  • 分析显示垂体腺瘤患者手术前后焦虑评分无显著差异,焦虑水平在手术后保持稳定。
  • 作者指出现有证据存在局限,缺乏共识可能受患者人群异质性、垂体腺瘤特征差异、治疗方式多样及潜在混杂因素影响。
  • 作者认为需要进一步研究以阐明垂体腺瘤手术与焦虑结局之间的细微关系。

研究设计与样本

  • 遵循PRISMA指南的系统综述与Meta分析,检索Embase、PubMed、Web of Sciences和Scopus至2022年10月。
  • 共纳入32项研究、2681例垂体腺瘤患者,平均年龄53.33±6.48岁,男性占43.4%。
  • 亚型分布:库欣病664例(25.8%)、肢端肥大症612例(23.8%)、泌乳素瘤282例(10.9%)、无功能垂体腺瘤969例(37.6%)。
  • Meta分析纳入17项研究、1510例患者,主要使用医院焦虑抑郁量表(HADS)和Zung焦虑自评量表(SAS)评估焦虑。

主要发现

  • 治疗方式:内镜下经蝶手术515例(29.8%),显微镜下经蝶手术222例(12.9%),977例(56.6%)未明确经蝶手术类型。
  • HADS评估:术前汇总评分8.27(95%CI 4.54-12.01),术后汇总评分6.49(95%CI 5.35-7.63),无显著差异。
  • SAS评估:术前汇总评分50.43(95%CI 37.40-63.45),术后汇总评分55.91(95%CI 49.40-62.41),无显著差异。
  • 垂体功能不全是原文报告的最常见并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出当前证据基础存在局限。
  • 缺乏共识可能受患者人群异质性、垂体腺瘤特征差异、治疗方式多样及潜在混杂因素(如既存心理健康状况和应对机制)影响。
  • 作者认为需要进一步研究,并采用严谨方法学处理潜在偏倚来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to evaluate the impact of surgical intervention on anxiety levels in patients with various types of pituitary adenoma (PA). METHOD: A systematic review was conducted following PRISMA guidelines until October 2022, searching Embase, PubMed, Web of Sciences, and Scopus. RESULTS: A total of 32 studies were included, encompassing 2,681 patients with the mean age of 53.33 ± 6.48 years (43.4% male). Among all subtypes, 664 diagnosed with Cushing's disease (25.8%), 612 with acromegaly (23.8%), 282 with prolactinoma (10.9%), and 969 with nonfunctional pituitary adenomas (37.6%). Pituitary insufficiency was the most common complication. Considering therapeutic modalities, 515 patients (29.8%) underwent endoscopic trans-sphenoidal surgery, while 222 (12.9%) underwent microscopic trans-sphenoidal surgery. The type of trans-sphenoidal surgery was not specified in 977 (56.6%) patients. A total of 17 studies including 1510 patients which mostly assessed anxiety using the Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety Scale (SAS) were included in the meta-analysis. Preoperative evaluation using Hospital Anxiety and Depression Scale (HADS) questionnaire showed a pooled score of 8.27 (95%CI 4.54-12.01), while postoperative evaluation yielded a pooled score of 6.49 (95%CI 5.35-7.63), indicating no significant difference. Preoperative SAS assessment resulted in a pooled score of 50.43 (95%CI 37.40-63.45), with postoperative pooled score of 55.91 (95%CI 49.40-62.41), showing no significant difference. CONCLUSIONS: Our analysis revealed no significant difference in anxiety scores pre- and postoperatively. While our findings suggest stability in anxiety levels following surgical intervention, it is imperative to recognize the limitations of the current evidence base. The observed lack of consensus may be influenced by factors such as the heterogeneous nature of the patient population, variations in the characteristics of pituitary adenomas, diverse therapeutic approaches, and potential confounding variables such as pre-existing mental health conditions and coping mechanisms. Further research is warranted to elucidate the nuanced relationship between surgical intervention for PA and anxiety outcomes, considering these complex interactions and employing rigorous methodologies to address potential sources of bias.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sabahi M, Yousefi O, Kehoe L, et al. Correlation Between Pituitary Adenoma Surgery and Anxiety Disorder: Systematic Review and Meta-Analysis. World Neurosurg. 2024. PMID: 38697260. doi:10.1016/j.wneu.2024.04.154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。